AUDREY GIBSON: Open Payments
NPI 1053346296 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$113,142 in 311 payments from 19 companies in 2025. Trend: 2023 $73,216 · 2024 $67,043 · 2025 $113,142
Speaker / faculty: $59,165Consulting: $26,073Travel & lodging: $21,164Food & beverage: $6,721Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 144 | $50,684 |
| Janssen Biotech, Inc. | 53 | $27,296 |
| Novartis Pharmaceuticals Corporation | 40 | $12,032 |
| Janssen Scientific Affairs, LLC | 7 | $7,118 |
| UCB, Inc. | 24 | $5,997 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $4,491 |
| GENZYME CORPORATION | 13 | $3,398 |
| Eli Lilly and Company | 1 | $1,600 |
| SOBI, INC | 2 | $143 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
Products named: TREMFYA, SKYRIZI, RINVOQ, Bimzelx, COSENTYX, KEVZARA, TALTZ, OFEV.
Industry payments across GA — which companies pay providers there.
